Special situation from BSE disclosures
iSERA Lifesciences Ltd · BSE 534920 · market cap ≈ ₹121 Cr at last filing
Formerly known as Covidh Technologies Ltd

Promoter-engineered reverse integration completed: iSERA Lifesciences allots ₹78 Cr share swap to 196 allottees expanding paid-up capital 192% — promoter PAC disclosure now confirms 38-member group holding 55.07% of enlarged capital, with Archana Lonkar individual disclosure adding final granular layer

Tracking since 2025-05-30 · 58 filings analysed · last filing 2026-10-07 · analysis updated 2026-10-07
Change of objectsAccumulationPromoter transitionTransformation · detected 2026-05-02Capital infusion · detected 2026-05-02Acquisition combination · detected 2026-07-17Accumulation · detected 2026-09-09
Triggering filing 2025-10-03 · stock +2038%* since · * unadjusted for a rights issue
Who's involved: Abhay Prabhakar Havaldar · Ashok Bhawandas Awtani · Dhairyasheel Vasantrao Yadav · Dilip Keshrimal Sanklecha · Jyoti Ketan Vakharia · Kallam Srinivas Reddy — full analysis of all actors on the Bench →
Closing price since 2025-10-03
Daily closes, adjusted for splits and bonuses · 2025-10-03 → 2026-10-05 · ₹6.7 → ₹143.9
Read the full situation analysis — who's involved, where the facts lean, what happened next
The full analysis names the people and entities involved with their documented history, shows where the filed facts lean for minority shareholders, and keeps tracking the situation as new filings arrive.
Filing timeline (from BSE disclosures)
2026-10-07Significant shareholder — stake change
2026-10-07Significant shareholder — stake change
2026-10-06Significant shareholder — stake change
2026-10-06New significant shareholder
2026-10-06Significant shareholder — stake change
2026-10-01Preferential allotment
2026-08-14Fundraising
2026-05-15Fundraising
Common questions (from the filings record)
What special situation is unfolding at iSERA Lifesciences Ltd?
Promoter-engineered reverse integration completed: iSERA Lifesciences allots ₹78 Cr share swap to 196 allottees expanding paid-up capital 192% — promoter PAC disclosure now confirms 38-member group holding 55.07% of enlarged capital, with Archana Lonkar individual disclosure adding final granular layer. Based on 58 BSE filings analysed; last filing 2026-10-07.
Who is involved at iSERA Lifesciences Ltd?
People named in the analysed filings include Abhay Prabhakar Havaldar, Ashok Bhawandas Awtani, Dhairyasheel Vasantrao Yadav, Dilip Keshrimal Sanklecha, Jyoti Ketan Vakharia and Kallam Srinivas Reddy.
When did Special Situations Bench first flag iSERA Lifesciences Ltd?
The triggering filing was on 2025-10-03. The stock has moved +2038%* since, adjusted for splits and bonuses (* unadjusted for a rights issue). Winners and losers are shown alike — this is not a recommendation.
What patterns have been detected at iSERA Lifesciences Ltd?
Detected patterns: Transformation (2026-05-02); Capital infusion (2026-05-02); Acquisition combination (2026-07-17); Accumulation (2026-09-09).
What flagged situations did next — a young track record
68%
of 72 flagged situations whose first 90 days completed were higher after the triggering filing
+10.3%
median 90-day move (mean +36.6%)
1 in 14 >2×
of 1,138 situations in a 2023–25 hindsight scan at least doubled within a year
Observational record, not performance of any portfolio. Live figures from 1 March 2026, measured as of 9 September 2026; the one-year set was identified in hindsight and is labelled as such. Moves are closing-price changes adjusted for splits and bonuses. Past movement does not indicate future movement.
What the Special Situations Bench is
The Bench scans every BSE corporate disclosure daily for event-driven special situations in Indian small- and micro-cap stocks — preferential allotments, open offers, changes of control, reverse mergers, accumulation by notable investors, debt settlements, capacity expansion and more.
Situations are flagged as the filings cluster — before they become stories — and every flagged situation is tracked against what the stock did next, winners and losers alike.
The full analysis connects the dots: what the filings add up to, the people and companies involved — with their documented history and a connections graph of how they link across other listed companies — and where the facts lean for minority shareholders.
About the Special Situations Bench →
Other situations with similar patterns
Special Situations Bench a Humdinger HQ product
situations.humdingerhq.ai is not a SEBI-registered research analyst. Nothing here is investment advice or a recommendation. Observations are drawn from public exchange disclosures.